Literature DB >> 26186740

Deficiency of adipocyte fatty-acid-binding protein alleviates myocardial ischaemia/reperfusion injury and diabetes-induced cardiac dysfunction.

Mi Zhou1, Yuqian Bao1, Haobo Li2, Yong Pan3, Lingling Shu3, Zhengyuan Xia4, Donghai Wu5, Karen S L Lam6, Paul M Vanhoutte7, Aimin Xu8, Weiping Jia9, Ruby L-C Hoo10.   

Abstract

Clinical evidence shows that circulating levels of adipocyte fatty-acid-binding protein (A-FABP) are elevated in patients with diabetes and closely associated with ischaemic heart disease. Patients with diabetes are more susceptible to myocardial ischaemia/reperfusion (MI/R) injury. The experiments in the present study investigated the role of A-FABP in MI/R injury with or without diabetes. Non-diabetic and diabetic (streptozotocin-induced) A-FABP knockout and wild-type mice were subjected to MI/R or sham intervention. After MI/R, A-FABP knockout mice exhibited reductions in myocardial infarct size, apoptotic index, oxidative and nitrative stress, and inflammation. These reductions were accompanied by an improved left ventricular function compared with the relative controls under non-diabetic or diabetic conditions. After diabetes induction, A-FABP knockout mice exhibited a preserved cardiac function compared with that in wild-type mice. Endothelial cells, but not cardiomyocytes, were identified as the most likely source of cardiac A-FABP. Cardiac and circulating A-FABP levels were significantly increased in mice with diabetes or MI/R. Diabetes-induced superoxide anion production was significantly elevated in wild-type mice, but diminished in A-FABP knockout mice, and this elevation contributed to the exaggeration of MI/R-induced cardiac injury. Phosphorylation of endothelial nitric oxide synthase (eNOS) and production of nitric oxide (NO) were enhanced in both diabetic and non-diabetic A-FABP knockout mice after MI/R injury, but diminished in wild-type mice. The beneficial effects of A-FABP deficiency on MI/R injury were abolished by the NOS inhibitor N(G)-nitro-L-arginine methyl ester. Thus, A-FABP deficiency protects mice against MI/R-induced and/or diabetes-induced cardiac injury at least partially through activation of the eNOS/NO pathway and reduction in superoxide anion production.
© 2015 Authors; published by Portland Press Limited.

Entities:  

Keywords:  adipocyte fatty-acid-binding protein; cardiac dysfunction; diabetes; endothelial nitric oxide synthase/nitric oxide (eNOS/NO) pathway; ischaemic heart disease; myocardial ischaemia/reperfusion

Mesh:

Substances:

Year:  2015        PMID: 26186740     DOI: 10.1042/CS20150073

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  19 in total

1.  Association of androgen with gender difference in serum adipocyte fatty acid binding protein levels.

Authors:  Xiang Hu; Xiaojing Ma; Xiaoping Pan; Yuqi Luo; Yiting Xu; Qin Xiong; Yuqian Bao; Weiping Jia
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

2.  N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.

Authors:  Wating Su; Yuan Zhang; Qiongxia Zhang; Jinjin Xu; Liying Zhan; Qiqi Zhu; Qingquan Lian; Huimin Liu; Zhong-Yuan Xia; Zhengyuan Xia; Shaoqing Lei
Journal:  Cardiovasc Diabetol       Date:  2016-10-12       Impact factor: 9.951

3.  Contribution of a first-degree family history of diabetes to increased serum adipocyte fatty acid binding protein levels independent of body fat content and distribution.

Authors:  X Hu; X Pan; X Ma; Y Luo; Y Xu; Q Xiong; Y Xiao; Y Bao; W Jia
Journal:  Int J Obes (Lond)       Date:  2016-09-13       Impact factor: 5.095

4.  A-FABP mediates adaptive thermogenesis by promoting intracellular activation of thyroid hormones in brown adipocytes.

Authors:  Lingling Shu; Ruby L C Hoo; Xiaoping Wu; Yong Pan; Ida P C Lee; Lai Yee Cheong; Stefan R Bornstein; Xianglu Rong; Jiao Guo; Aimin Xu
Journal:  Nat Commun       Date:  2017-01-27       Impact factor: 14.919

5.  Contribution of serum adipocyte fatty acid-binding protein levels to the presence of microalbuminuria in a Chinese hyperglycemic population.

Authors:  Xiang Hu; Xiaojing Ma; Yuqi Luo; Yiting Xu; Qin Xiong; Xiaoping Pan; Yuqian Bao; Weiping Jia
Journal:  J Diabetes Investig       Date:  2017-01-31       Impact factor: 4.232

6.  Adipocyte Fatty Acid Binding Protein Potentiates Toxic Lipids-Induced Endoplasmic Reticulum Stress in Macrophages via Inhibition of Janus Kinase 2-dependent Autophagy.

Authors:  Ruby L C Hoo; Lingling Shu; Kenneth K Y Cheng; Xiaoping Wu; Boya Liao; Donghai Wu; Zhiguang Zhou; Aimin Xu
Journal:  Sci Rep       Date:  2017-01-17       Impact factor: 4.379

7.  Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells.

Authors:  Xiaoping Wu; Lingling Shu; Zixuan Zhang; Jingjing Li; Jiuyu Zong; Lai Yee Cheong; Dewei Ye; Karen S L Lam; Erfei Song; Cunchuan Wang; Aimin Xu; Ruby L C Hoo
Journal:  Adv Sci (Weinh)       Date:  2021-03-27       Impact factor: 16.806

8.  Macrophages induce the expression of lncRNA ATB via the secretion of TGF-β to relieve ischemia-reperfusion injury in cardiomyocytes.

Authors:  Hong Lin; Wen-Sheng Xu; Xiong-Wei Liu; Zhi Wang; Jiao Yan; Tao Zhang
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

9.  Cardiomyocyte Overexpression of FABP4 Aggravates Pressure Overload-Induced Heart Hypertrophy.

Authors:  Ji Zhang; Congzhen Qiao; Lin Chang; Yanhong Guo; Yanbo Fan; Luis Villacorta; Y Eugene Chen; Jifeng Zhang
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

10.  Polydatin Protects Diabetic Heart against Ischemia-Reperfusion Injury via Notch1/Hes1-Mediated Activation of Pten/Akt Signaling.

Authors:  Liming Yu; Zhi Li; Xue Dong; Xiaodong Xue; Yu Liu; Shu Xu; Jian Zhang; Jinsong Han; Yang Yang; Huishan Wang
Journal:  Oxid Med Cell Longev       Date:  2018-02-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.